Gsa Capital Partners LLP Albireo Pharma, Inc. Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$18.54 - $37.29 $186,864 - $375,845	10,079 New	10,079 $200,000
Q1 2022 May 11, 2022	SELL	$23.94 - $33.74 $497,521 - $701,184	-20,782 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.19 - $31.29 $186,662 - $275,633	8,809 Added 73.57%	20,782 $484,000
Q3 2021 Nov 12, 2021	BUY	$27.36 - $35.98 $327,581 - $430,788	11,973 New	11,973 $374,000
Q2 2020 Aug 11, 2020	SELL	$14.82 - $29.92 $204,323 - $412,507	-13,787 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$11.67 - $27.23 $160,894 - $375,420	13,787 New	13,787 $226,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.